Coppa Collective plc (AIM:COPC)
London · Delayed Price · Currency is GBP · Price in GBX 14.50
0.00 (0.00%)
At close: Apr 17, 2026
Coppa Collective Revenue
In the fiscal year ending September 28, 2025, Coppa Collective had annual revenue of 52.38M GBP with 5.84% growth. Coppa Collective had revenue of 27.72M in the half year ending September 28, 2025, with 11.25% growth.
Revenue
52.38M
Revenue Growth
+5.84%
P/S Ratio
0.48
Revenue / Employee
55.78K
Employees
939
Market Cap
25.38M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 28, 2025 | 52.38M | 2.89M | 5.84% |
| Sep 29, 2024 | 49.49M | 3.99M | 8.77% |
| Oct 1, 2023 | 45.50M | 4.83M | 11.87% |
| Oct 2, 2022 | 40.67M | 18.32M | 81.97% |
| Oct 3, 2021 | 22.35M | 5.88M | 35.70% |
| Sep 27, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 29, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 1, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 2, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| TheWorks.co.uk | 276.68M |
| Goldplat | 72.22M |
| Checkit | 14.30M |
| Roebuck Food Group | 10.97M |
| SkinBioTherapeutics | 4.64M |
| The Parkmead Group | 3.47M |
| Arecor Therapeutics | 1.71M |
| Provexis | 871.27K |